March 2008
... † The Approval Date is established by the FDA, but does not necessarily mean a generic product is available as of that date, or that such product is available. ‡ This Launch Date/Anticipated Launch Date may not reflect the date of availability for this medication. Due to circumstances beyond the con ...
... † The Approval Date is established by the FDA, but does not necessarily mean a generic product is available as of that date, or that such product is available. ‡ This Launch Date/Anticipated Launch Date may not reflect the date of availability for this medication. Due to circumstances beyond the con ...
Efficacy and safety of mometasone furoate nasal spray in allergic
... evaluation of total nasal symptom scores at day 8, all three dosages of MFNS and the twice-daily dosage of BDP nasal spray afforded significantly greater relief than placebo (p ≤ 0.02). At 4 weeks, both the 100 µg (p = 0.03) and 200 µg (p = 0.04) daily doses of MFNS were significantly more effective ...
... evaluation of total nasal symptom scores at day 8, all three dosages of MFNS and the twice-daily dosage of BDP nasal spray afforded significantly greater relief than placebo (p ≤ 0.02). At 4 weeks, both the 100 µg (p = 0.03) and 200 µg (p = 0.04) daily doses of MFNS were significantly more effective ...
JNC_8-13120583 - Indian Association of Clinical Cardiologists
... Does initiating antihypertensive pharmacologic therapy at specific BP thresholds improve health outcomes? Does treatment with antihypertensive pharmacologic therapy to a specified BP goal lead to improvements in health outcomes? Do various antihypertensive drugs or drug classes differ in compara ...
... Does initiating antihypertensive pharmacologic therapy at specific BP thresholds improve health outcomes? Does treatment with antihypertensive pharmacologic therapy to a specified BP goal lead to improvements in health outcomes? Do various antihypertensive drugs or drug classes differ in compara ...
| Linezolid to treat MDR-/XDR-tuberculosis: available evidence and future scenarios Giovanni Sotgiu
... on linezolid reports a proportion of adverse events far below the average (0% undergoing therapeutic drug monitoring versus 59% not undergoing monitoring). Nevertheless, the greatest limit to this approach is the paucity of laboratories that are able to perform linezolid therapeutic drug monitoring ...
... on linezolid reports a proportion of adverse events far below the average (0% undergoing therapeutic drug monitoring versus 59% not undergoing monitoring). Nevertheless, the greatest limit to this approach is the paucity of laboratories that are able to perform linezolid therapeutic drug monitoring ...
Mark Palla Street Drugs
... Many PCP users are brought to emergency rooms because of PCP's unpleasant psychological effects or because of overdoses. In a hospital or detention setting, they often become violent or suicidal, and are very dangerous to themselves and to others. They should be kept in a calm setting and should not ...
... Many PCP users are brought to emergency rooms because of PCP's unpleasant psychological effects or because of overdoses. In a hospital or detention setting, they often become violent or suicidal, and are very dangerous to themselves and to others. They should be kept in a calm setting and should not ...
A Quick Reference to Drugs commonly used in the
... Patients with renal failure, impaired hearing or vestibular defects, previous hypersensitivity to Amikacin. Contraindicated in myasthenia gravis. Caution in neonates Ototoxicity, renal toxicity, peripheral neuropathy, hypersensitivity, skin rash Peak > 30 mg/L; trough < 1 mg/L <10 years – 25 mg/kg d ...
... Patients with renal failure, impaired hearing or vestibular defects, previous hypersensitivity to Amikacin. Contraindicated in myasthenia gravis. Caution in neonates Ototoxicity, renal toxicity, peripheral neuropathy, hypersensitivity, skin rash Peak > 30 mg/L; trough < 1 mg/L <10 years – 25 mg/kg d ...
Suicidality and Antidepressant Drugs Antidepressants
... whereas cytochrome 3A is considered to be responsible for the formation of the Ndesmethyl and N-oxide metabolite. Mirtazapine has an absolute bioavailability of about 50%. It is eliminated predominantly via urine (75%) with 15% in feces. Several unconjugated metabolites possess pharmacological activ ...
... whereas cytochrome 3A is considered to be responsible for the formation of the Ndesmethyl and N-oxide metabolite. Mirtazapine has an absolute bioavailability of about 50%. It is eliminated predominantly via urine (75%) with 15% in feces. Several unconjugated metabolites possess pharmacological activ ...
Vetsulin® and Feline Diabetes Mellitus
... Vetsulin is classified as an intermediate-acting insulin. In cats, the peak activity following subcutaneous administration of Vetsulin is generally expected to be around 4 hours, but can occur between 1.5 and 8 hours. The duration of activity can vary between 8 and 12 hours. The peak, duration of ac ...
... Vetsulin is classified as an intermediate-acting insulin. In cats, the peak activity following subcutaneous administration of Vetsulin is generally expected to be around 4 hours, but can occur between 1.5 and 8 hours. The duration of activity can vary between 8 and 12 hours. The peak, duration of ac ...
Abstral - AZBlue
... ORIGINAL EFFECTIVE DATE: LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE: ...
... ORIGINAL EFFECTIVE DATE: LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE: ...
Pharm II - 2-22
... a. High potency typicals have a reduced risk of EPS b.Low potency typicals are less efficacious than higher potency antipsychotics c. Atypical antipsychotics have increased affinity for D2 as compared to typical antipsychotics d.Increased anticholinergic activity reduces the risk of EPS ...
... a. High potency typicals have a reduced risk of EPS b.Low potency typicals are less efficacious than higher potency antipsychotics c. Atypical antipsychotics have increased affinity for D2 as compared to typical antipsychotics d.Increased anticholinergic activity reduces the risk of EPS ...
Myfortic - Novartis Pharmaceuticals Corporation
... other immunosuppressive agents. The mechanism for MPA derivatives induced PRCA is unknown; the relative contribution of other immunosuppressants and their combinations in an immunosuppressive regimen is also unknown. In some cases PRCA was found to be reversible with dose reduction or cessation of t ...
... other immunosuppressive agents. The mechanism for MPA derivatives induced PRCA is unknown; the relative contribution of other immunosuppressants and their combinations in an immunosuppressive regimen is also unknown. In some cases PRCA was found to be reversible with dose reduction or cessation of t ...
Inspra for heart failure
... CV mortality occurred in 10.8% of patients in the eplerenone group and 13.5% in the placebo group. The difference in time-to-event was statistically significant favouring eplerenone (HR, 0.76; 95% CI, 0.61-0.94). The benefit on CV mortality was not observed in patients who are 75 years or older. ...
... CV mortality occurred in 10.8% of patients in the eplerenone group and 13.5% in the placebo group. The difference in time-to-event was statistically significant favouring eplerenone (HR, 0.76; 95% CI, 0.61-0.94). The benefit on CV mortality was not observed in patients who are 75 years or older. ...
Marijuana
... Sinsemilla (made from just the buds & flowering tops of female plants – no seeds) has 7.5% THC (up to 24%). Hashish (sticky resin from the female plant flowers) has 3.6% (up to 28%). Hash oil, a tar-like liquid distilled from hashish, has 16% (up to 43%). ...
... Sinsemilla (made from just the buds & flowering tops of female plants – no seeds) has 7.5% THC (up to 24%). Hashish (sticky resin from the female plant flowers) has 3.6% (up to 28%). Hash oil, a tar-like liquid distilled from hashish, has 16% (up to 43%). ...
ISMP Medication Safety Alert - Institute For Safe Medication Practices
... When prescribing either drug, the drug name should be printed, and the purpose of the drug should be listed. In pharmacies, the products should not be stored near each other, and tall man letters should be used for storage labeling and computer ...
... When prescribing either drug, the drug name should be printed, and the purpose of the drug should be listed. In pharmacies, the products should not be stored near each other, and tall man letters should be used for storage labeling and computer ...
glycerin - DavisPlus
... Use Cautiously in: Severe dehydration; Geriatric patients (increased risk of dehydration). ...
... Use Cautiously in: Severe dehydration; Geriatric patients (increased risk of dehydration). ...
CARDIOVASCULAR PHARMACOLOGY
... Many days to full anticoagulation due to different T ½ of various clotting factors Factor ...
... Many days to full anticoagulation due to different T ½ of various clotting factors Factor ...
Hallucinogens - People Server at UNCW
... getting to cortex through overriding filter mechanisms ...
... getting to cortex through overriding filter mechanisms ...
vitekta - Gilead
... Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The safety assessment of VITEKTA is ...
... Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. The safety assessment of VITEKTA is ...
Sedatives
... o Eszopiclone/Zolpidem/Zaleplon: hypnotics that modulate GABAA receptor via interaction with BZ binding site (but these are NOT benzos) ...
... o Eszopiclone/Zolpidem/Zaleplon: hypnotics that modulate GABAA receptor via interaction with BZ binding site (but these are NOT benzos) ...
Microdose and microtracer information sheet
... dosing at a clinical dose is impractical. Examples are studies with cytotoxic molecules, potent drugs, or drugs with extremely long half-lives where drug and radioactivity exposure to the subject may be a concern. ...
... dosing at a clinical dose is impractical. Examples are studies with cytotoxic molecules, potent drugs, or drugs with extremely long half-lives where drug and radioactivity exposure to the subject may be a concern. ...
ANTIDIABETIC ACTIVITY OF SOME HERBAL DRUG
... blood rises over the normal range of between 95-110 mmol/dL to values much higher than these. Treatment of diabetes entails injecting the patients with drugs that works towards enacting processes that tend to correct the sugar levels in the blood. In some rare cases, hypoglycemic condition arises in ...
... blood rises over the normal range of between 95-110 mmol/dL to values much higher than these. Treatment of diabetes entails injecting the patients with drugs that works towards enacting processes that tend to correct the sugar levels in the blood. In some rare cases, hypoglycemic condition arises in ...
SANTEN RECEIVES FDA APPROVAL OF IQUIX
... “A corneal ulcer is potentially sight threatening due to its residual scarring,” explained Richard L. Lindstrom, M.D., Adjunct Professor Emeritus at the University of Minnesota and Founder and Managing Partner of Minnesota Eye Consultants, PA. “IQUIX’s high concentration has positive implications fo ...
... “A corneal ulcer is potentially sight threatening due to its residual scarring,” explained Richard L. Lindstrom, M.D., Adjunct Professor Emeritus at the University of Minnesota and Founder and Managing Partner of Minnesota Eye Consultants, PA. “IQUIX’s high concentration has positive implications fo ...
tablet (ODT) - Rajiv Gandhi University of Health Sciences
... swallowing conventional tablets may be difficult. This paper summarizes the formulation methods and drug formulation coming in market.[14] 8. The present work aimed at preparing quick release films of levocetirizine dihydrochloride with the purpose of developing a dosage form for a very quick onset ...
... swallowing conventional tablets may be difficult. This paper summarizes the formulation methods and drug formulation coming in market.[14] 8. The present work aimed at preparing quick release films of levocetirizine dihydrochloride with the purpose of developing a dosage form for a very quick onset ...
ACUTE RENAL FAILURE
... (24%) patients had pre-existing renal disease. The medicines most frequently implicated were nonsteroidal anti-inflammatory drugs (NSAIDs), proton pump inhibitors (PPIs) and antibiotics. The majority of patients with ARF attributed to NSAIDs were taking the maximum recommended or supra-therapeutic d ...
... (24%) patients had pre-existing renal disease. The medicines most frequently implicated were nonsteroidal anti-inflammatory drugs (NSAIDs), proton pump inhibitors (PPIs) and antibiotics. The majority of patients with ARF attributed to NSAIDs were taking the maximum recommended or supra-therapeutic d ...
Bilastine
Bilastine (trade name Bilaxten) is a second generation antihistamine drug for the treatment of allergic rhinoconjunctivitis and urticaria (hives).It exerts its effect as a selective histamine H1 receptor antagonist, and has a effectiveness similar to cetirizine, fexofenadine and desloratadine. It was developed in Spain by FAES Farma.Bilastine is approved in the European Union for the symptomatic treatment of allergic rhinoconjunctivitis and urticaria, but it is not approved by the U.S. Food and Drug Administration for any use in the United States. Bilastine meets the current European Academy of Allergy and Clinical Immunology (EAACI) and Allergic Rhinitis and its Impact of Asthma (ARIA) criteria for medication used in the treatment of allergic rhinitis.Bilastine has been effective in the treatment of ocular symptoms and diseases of allergies, including rhinoconjuctivitis. Additionally, bilastine has been shown to improve quality of life, and all nasal and ocular symptoms related to allergic rhinitis.